| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 09/18/2007 | US7271188 e.g. 4-[3'-(3''-aminosulfonylpropyl)-4',4'-dimethyl-5'-oxo-2'-thioxo-1'-imidazolidinyl]-2-trifluoromethylbenzonitrile; anti-androgen agent which has a sufficient antagonistic effect and reduced side effect profile |
| 09/18/2007 | US7271185 Optically active azole derivative and process for producing the same |
| 09/13/2007 | WO2007103719A2 MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| 09/13/2007 | WO2007102580A1 Polycyclic cinnamide derivative |
| 09/13/2007 | WO2007102253A1 Metal-coated lipid bimolecular membrane endoplasmic reticulum and process for producing the same |
| 09/13/2007 | WO2007101802A1 4-amino-1,5-substituted 1,5-dihydro-imidazol-2-ones |
| 09/13/2007 | WO2006121528A3 Ring closing and related methods and intermediates |
| 09/13/2007 | WO2006099567A3 Biocidal n-halamine epoxides |
| 09/13/2007 | US20070213364 Alkoxyphenylpropanoic Acid Derivatives |
| 09/13/2007 | US20070213347 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction |
| 09/13/2007 | US20070213333 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
| 09/13/2007 | US20070213329 Sulphones which modulate the action of gammasecretase |
| 09/13/2007 | US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/13/2007 | US20070212709 Non-nucleosidic linker linking xanthene donor to 4,7-dichlororhodamine acceptor; |
| 09/13/2007 | DE102006011077A1 Verfahren zum Abbau von Cellulose mit Nucleophilen A method for degradation of cellulose with nucleophiles |
| 09/13/2007 | DE102006011076A1 Verfahren zum Abbau von Cellulose A method for degradation of cellulose |
| 09/13/2007 | DE102006011075A1 Verfahren zum Abbau von Cellulose in Lösung Process for the degradation of cellulose in solution |
| 09/13/2007 | CA2643796A1 Polycyclic cinnamide derivatives |
| 09/13/2007 | CA2642859A1 4-amino-1,5-substituted 1,5-dihydro-imidazol-2-ones |
| 09/12/2007 | EP1831185A1 Triazolone, tetrazolone and imidazolone derivatives for use as alpha-2c adrenoreceptor antagonists |
| 09/12/2007 | EP1831179A1 Method for the production of onium salts with tetrafluoroborate anion having a reduced halide content |
| 09/12/2007 | EP1831159A1 Tetralin and indane derivatives and uses thereof |
| 09/12/2007 | EP1831158A1 Novel cyclohexane derivatives |
| 09/12/2007 | EP1395566B1 Tricyclic compounds useful as angiotensin ii agonists |
| 09/12/2007 | EP1379239B1 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor |
| 09/12/2007 | EP1372615A4 Compounds and compositions for delivering active agents |
| 09/12/2007 | EP1019358B2 3,3-diarylpropylamines , their use and preparation |
| 09/12/2007 | CN101033213A Phenylalanine-1-methyl-3-butyl-imidazole amino acid ionic liquid and preparing method thereof |
| 09/12/2007 | CN100336809C Peptide deformylase inhibitors |
| 09/11/2007 | US7268233 Nickel-carbene, palladium-carbene and platinum-carbene complexes, their production and use in catalytic reactions |
| 09/11/2007 | US7268132 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder |
| 09/11/2007 | US7268115 Cyclic peptides; three-dimensional structures; screening; anticancer agents; angiogenesis inhibitors; drug delivery |
| 09/11/2007 | CA2433839C Primary intermediates for oxidative coloration of hair |
| 09/11/2007 | CA2070419C Synthesis and use of amino acid fluorides as peptide coupling reagents |
| 09/07/2007 | WO2007100047A1 Method for producing 2-imidazolidinone compound and 4,5-dialkoxy-2-imidazolidinone compound |
| 09/07/2007 | WO2007099934A1 Aliphatic amino acid labeled with stable isotope, method of inserting the same in target protein, and method of nmr conformation analysis of protein |
| 09/07/2007 | WO2007098826A2 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 09/07/2007 | WO2007022173A3 Crystalline forms fenoldopam mesylate |
| 09/07/2007 | WO2006041888A3 Substituted aryl or heteroarylsulfonylbutanamides for use as anti-inflammatory agents |
| 09/07/2007 | CA2643994A1 Stable isotope-labeled aliphatic amino acids, method for incorporating the same in target protein and method for nmr-structural analysis of proteins |
| 09/07/2007 | CA2643021A1 Imidazole-based compounds, compositions comprising them and methods of their use |
| 09/07/2007 | CA2637530A1 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 09/06/2007 | US20070208181 reduced or no emetogenic effects ; benzylated phosphodiesterase 4 inhibitors; e.g. Rolipram, Ariflo, Arofylline; preparation by benzylation using benzyl bromide or a derivative; antiinflammatory agents; to treat autoimmune diseases; cystic fibrosis |
| 09/06/2007 | US20070208166 Tao Kinase Modulators And Method Of Use |
| 09/06/2007 | US20070208070 2-thioxo-4-imidazolines; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders |
| 09/06/2007 | US20070208064 Ion channel modulators |
| 09/06/2007 | US20070208059 Therapeutic Agents |
| 09/06/2007 | US20070208048 New Aryl Imidazoles and Related Compounds as C5a Receptor Modulators |
| 09/06/2007 | US20070208033 Amine compound and use thereof |
| 09/06/2007 | US20070208007 Amine-Based Compound and Use Thereof |
| 09/05/2007 | EP1828218A1 Synthesis of phosphitylated compounds using a quaternary heterocyclic activator |
| 09/05/2007 | EP1828142A1 Method for producing onium alkyl sulfates with a low halogenide content |
| 09/05/2007 | EP1828141A1 A one-pot process for the preparation of antiemetic agent, 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl)-1h-imidazole-1-yl)methyl]-4h-carbazol-4-o |
| 09/05/2007 | EP1689698A4 Bis-cationic compounds and use thereof |
| 09/05/2007 | EP1373233B1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 09/05/2007 | EP1289949B1 Method for the production of caprolactam |
| 09/05/2007 | CN101031562A Imidazole-5-carboxylic acid derivative, its production and use |
| 09/05/2007 | CN101031549A 4-(phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists |
| 09/05/2007 | CN101031539A Substituted arylalkanoic acid derivatives and use thereof |
| 09/05/2007 | CN101029397A Surface treating agent and method for manufacturing coating using the same |
| 09/05/2007 | CN101029033A Production of N-contained pentabasic heteroaromatic dimethyl ether |
| 09/05/2007 | CN101029026A Method for synthesizing piperidyl sulfur-family carbene compound |
| 09/04/2007 | US7265246 7-Aminoakyl-2-arylcarbonylaminoindanes, e.g., 3-Fluorobiphenyl-4-carboxylic acid (R)-(6-((3-ethoxypropylamino)methyl)-2R-hydroxyindan-1-yl)amide; treatment of cognitive impairment associated with schizophrenia, Alzheimer's disease, and psychoses |
| 09/04/2007 | US7265143 C-4 substituted retinoids |
| 09/04/2007 | US7265138 inflammatory or neuropathic pain and diseases involving sensory nerve function such as asthma, rheumatoid arthritis, osteoarthritis, inflammatory bowel disorders, urinary incontinence, migraine and psoriasis |
| 09/04/2007 | US7265137 Phenylacetic acid derivative; hypoglycemic agents; antilipemic agents; anticholesterol agents; cardiovascular disorders |
| 09/04/2007 | US7265135 Antihistamines; cognition activators; Alzheimer's disease; antiepileptic agents; eating disorders; motion sickness; psychological disorders |
| 09/04/2007 | US7265130 anti-obestic activity; Neuropeptide Y antagonist |
| 08/30/2007 | WO2007096259A1 Hydantoin based kinase inhibitors |
| 08/30/2007 | WO2007095789A1 Imidazol-5-carboxylic acid derivatives, preparation methods and use therrof |
| 08/30/2007 | WO2007034326A3 Imidazole compounds for the treatment of neurological disorders |
| 08/30/2007 | WO2006127503A3 Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders |
| 08/30/2007 | US20070203345 Ambient-temperature molten salts and process for producing the same |
| 08/30/2007 | US20070203344 Synthesis of imidazole 2-thiones via thiohydantoins |
| 08/30/2007 | US20070203338 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
| 08/30/2007 | US20070203215 Methods & Compositions For Enhancing Pharmaceutical Treatments |
| 08/30/2007 | US20070203207 Heteroaromatic glucokinase activators |
| 08/30/2007 | US20070203205 treatment and/or prevention of adverse conditions of the central nervous system, including sleep disorders such as insomnia, psychotic disorders such as schizophrenia and psychiatric disorders such as anxiety; example (1S)-1-[2-({4-[(E)-2-(4-fluorophenyl)vinyl]phenyl}sulfonyl)phenyl]ethanol |
| 08/30/2007 | US20070203198 Pioglitazone insulin sensitivity enhancer with the antidiabetic glimepiride; difference in mechanism of action avoids adverse reactions over long term use; oral dosage tablet; lactose excipient, hydroxypropylcellulose binder, magnesium stearate lubricant, calcium carbonate disintegrator; diabetes |
| 08/30/2007 | US20070202160 Solid-state form of celecoxib having enhanced bioavailability |
| 08/30/2007 | CA2642794A1 Hydantoin based kinase inhibitors |
| 08/29/2007 | EP1824831A2 Histone deacetylase inhibitors |
| 08/29/2007 | EP1824827A1 Method for producing onium salts comprising alkyl anions or aryl sulfonate anions or alkyl anions or aryl carboxylate anions having a low halide content |
| 08/29/2007 | EP1824817A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 08/29/2007 | EP1824805A1 Method for preparation of organofluoro compounds in alcohol solvents |
| 08/29/2007 | EP1489070B1 Process for production of optically active compounds |
| 08/29/2007 | EP1235786B1 Method for the preparation of enantiomerically enriched compounds |
| 08/29/2007 | EP1024814B1 Use of antifungal agents for the topical treatment of fungus-induced mucositis |
| 08/29/2007 | CN200940124Y Gas-liquid phrase synthesis installation for producing imidazole |
| 08/29/2007 | CN101027287A Method of manufacturing 2-chloro-4-nitroimidazole |
| 08/29/2007 | CN101024630A Process for preparing intermediate 2-oxo-imidazolidame derivative |
| 08/29/2007 | CN101024629A Stable imidazoline solutions |
| 08/28/2007 | US7262318 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 08/28/2007 | US7261743 Dicationic compounds for dyeing human keratin fibers, and compositions comprising them |
| 08/28/2007 | CA2405072C Gel compositions containing metronidazole |
| 08/28/2007 | CA2210889C Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 08/23/2007 | WO2007073518A9 Compounds and methods for thiol-containing compound efflux and cancer treatment |
| 08/23/2007 | US20070197795 Method of making imidazole-2-ones and 2-thiones |
| 08/23/2007 | US20070197793 Imidazolic compounds and use thereof as alpha-2 adrenergic receptors |
| 08/23/2007 | US20070197622 Methods for treating CNS disorders with 4-imidazole derivatives |